Review summary:
This paper proposes TimeWarn, an interpretable two-level attention model that explicitly incorporates irregular time intervals between EHR measurements by learning a decay that modulates both visit-level and variable-level attention. On MIMIC-IV and eICU, it achieves consistent improvements over strong baselines (GRU-D, RETAIN) for 6-hour-ahead sepsis prediction and provides attention analyses aligning with clinical intuition.

Strengths:
- Addresses a clinically important task with clear motivation for handling irregular sampling.
- Simple, interpretable extension to RETAIN that incorporates elapsed time at both attention levels.
- Solid empirical evaluation on two large public ICU datasets with multiple baselines and ablation.
- Gains are consistent across datasets; attention weights highlight clinically meaningful variables.
- Includes lead-time analysis beyond the primary 6-hour horizon.

Weaknesses and concerns:
- Novelty is incremental relative to prior art on irregular time and interpretable EHR models (e.g., GRU-D, RETAIN variants, time-aware attention/hierarchical models).
- Potential fairness issue in model selection: TimeWarn is tuned via grid search per dataset while baselines reportedly use hyperparameters from original papers; stronger hyperparameter tuning for GRU-D/RETAIN/XGBoost might narrow the gap.
- Methodological clarity: it is not fully specified whether the time-decay scaling is applied before or after attention softmax and whether attentions are re-normalized; this affects interpretability and contribution weighting.
- Reproducibility details are light (exact variable list, preprocessing/imputation, handling of missingness, censoring of treatment variables tied to Sepsis-3 label to avoid leakage, calibration metrics).
- Clinical utility not assessed prospectively; no analysis of alert burden or calibration, which are important for deployment.

Questions and suggestions for authors:
- Clarify where the decay is applied in the attention pipeline (pre/post-softmax) and whether you re-normalize.
- Report stronger hyperparameter tuning for baselines (or show robustness to tuning choices) to ensure fairness.
- Provide details on feature set and preprocessing (imputation strategy, normalization, handling of demographics), and explicitly state whether orders for cultures/antibiotics or vasopressors were excluded from predictors to avoid label leakage.
- Add calibration metrics (e.g., ECE, reliability plots) and decision-focused metrics (PPV at fixed sensitivity) at clinically relevant operating points.
- Consider reporting AUROC/AUPRC at multiple horizons in the main table and include confidence intervals in addition to seed-based standard deviations.
- Release code and preprocessing pipelines to support reproducibility.

Scores:
- Soundness: 78/100
- Novelty: 65/100
- Significance: 75/100
- Clarity: 85/100

Final average score: 75.8/100

Final recommendation: Accept

Rationale: Although the methodological novelty is modest, the paper is well-motivated, clearly written, and demonstrates consistent, meaningful improvements with interpretability on two large public datasets, supported by ablation and analysis. With minor clarifications and stronger baseline tuning, this would make a solid, practical contribution to early sepsis prediction from irregular EHR data.